VEGFA and diabetic kidney disease: When upregulation of vascular endothelial growth factor (VEGF) was first described in the kidneys of rats with experimental diabetes over a decade ago [1], its role in the pathogenesis of diabetic nephropathy appeared straightforward: either increased glomerular VEGF was deleterious or increased glomerular VEGF conferred compensatory renoprotection.